ACHV Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
Cost of Revenue
0
0
0
0
0
Gross Profit
Operating Expenses
10.5M
-30.9%
15.1M
+3.0%
14.7M
+16.9%
12.6M
-2.6%
12.9M
R&D
3.3M
-15.0%
3.9M
-27.2%
5.3M
-20.7%
6.7M
-5.5%
7.1M
SG&A
7.2M
-34.0%
10.9M
+15.8%
9.4M
+60.0%
5.9M
+1.0%
5.8M
Operating Income
-10463000
+30.9%
-15139000
-3.0%
-14692000
-16.9%
-12563000
+2.6%
-12894000
EBITDA
-10406000
+29.1%
-14674000
-0.2%
-14638000
-17.0%
-12508000
+2.5%
-12832000
Net Income
-10168000
+30.7%
-14662000
-1.5%
-14441000
-13.5%
-12718000
+0.8%
-12827000
EPS (Basic)
$-0.19
+26.9%
$-0.26
+7.1%
$-0.28
+24.3%
$-0.37
+0.0%
$-0.37
EPS (Diluted)
$-0.19
+26.9%
$-0.26
+7.1%
$-0.28
+24.3%
$-0.37
+0.0%
$-0.37
Shares (Diluted)
53.4M
+22.5%
43.6M
-14.5%
51.0M
+47.1%
34.7M
+0.0%
34.7M
Achieve Life Sciences (ACHV) — Financials